Conference item icon

Conference item

CAMPATH-1H in inflammatory arthritis.

Abstract:
CAMPATH-1H is a humanised mAb directed against lymphocytes. This mAb has been used to treat patients with rheumatoid arthritis. Clinical improvement with reduction in the Ritchie index and joint score has lasted for up to 8 months in some patients. A profound and prolonged lymphopaenia is induced by the mAb, with CD4+ numbers remaining suppressed for up to one year.
Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pathology Dunn School
Role:
Author


Journal:
Clinical and experimental rheumatology More from this journal
Volume:
11 Suppl 8
Pages:
S165-S167
Publication date:
1993-01-01
Event title:
2ND INTERNATIONAL SYMP ON THE IMMUNOTHERAPY OF THE RHEUMATIC DISEASES ( PREPRINTS )
ISSN:
0392-856X


Keywords:
Pubs id:
pubs:28383
UUID:
uuid:7de70dc9-63dd-4b28-a640-5f87ee6d206c
Local pid:
pubs:28383
Source identifiers:
28383
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP